Acell Inc logo

ACLL - Acell Inc Share Price

n/a 0.0  0.0%

Last Trade -

Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £72.7m
Position in Universe th / 6927
Unlock ACLL Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 89.2 100.8 +13.0%
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Acell Increvenues decreased 2% to $23.7M. Net loss totaled $2.7M vs.income of $66K. Revenues reflect a decrease in demand forthe Company's products and services due to unfavorablemarket conditions. Net loss reflects Selling, general andadministr increase of 15% to $19.8M (expense), Stock-basedCompensation in SGA increase of 44% to $256K (expense),Interest income decrease of 42% to $24K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ACLL Revenue Unlock ACLL Revenue

Net Income

ACLL Net Income Unlock ACLL Revenue

Normalised EPS

ACLL Normalised EPS Unlock ACLL Revenue

PE Ratio Range

ACLL PE Ratio Range Unlock ACLL Revenue

Dividend Yield Range

ACLL Dividend Yield Range Unlock ACLL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ACLL EPS Forecasts Unlock ACLL Revenue
Profile Summary

ACell, Inc. is a regenerative medicine company. The Company is focused on the development, manufacture and sale of products primarily used in acute care settings as part of the treatment and management of moderate to severe wounds and reinforcement of soft tissue surgical defects. Its products utilize its porcine urinary bladder matrix platform technology. It manufactures extracellular matrix (ECM), products that utilize porcine urinary bladder matrix (UBM). It markets MicroMatrix, a particulate formulation, and Cytal Wound Matrix products, in sheet formulations, for the management of acute, surgical, chronic and tunneling wounds and partial thickness burns. It also markets Gentrix Surgical Matrix products, in sheet formulations, for the reinforcement of soft tissue in certain surgical applications, such as for hernia repair.

Last Annual December 31st, 2019
Last Interim March 31st, 2020
No. of Shareholders: n/a
No. of Employees: 400
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange NASDAQ Global Select Market
Shares in Issue 22,675,510
Free Float (0.0%)
Eligible for
ACLL Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ACLL
Upcoming Events for ACLL
Frequently Asked Questions for Acell Inc
What is the Acell Inc share price?

As of , shares in Acell Inc are trading at n/a, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Acell Inc share price performed this year?

Shares in Acell Inc are currently trading at n/a and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Acell Inc price has moved by % over the past year.

What are the analyst and broker recommendations for Acell Inc?

There are no analysts currently covering Acell Inc.

When will Acell Inc next release its financial results?

Acell Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Acell Inc dividend yield?

Acell Inc does not currently pay a dividend.

Does Acell Inc pay a dividend?

Acell Inc does not currently pay a dividend.

When does Acell Inc next pay dividends?

Acell Inc does not currently pay a dividend.

How do I buy Acell Inc shares?

To buy shares in Acell Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Acell Inc?

Shares in Acell Inc are currently trading at n/a, giving the company a market capitalisation of £n/a.

Where are Acell Inc shares listed? Where are Acell Inc shares listed?

Here are the trading details for Acell Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: ACLL
What kind of share is Acell Inc?

We were not able to load our ranking data for Acell Inc

Is there a Acell Inc share price forecast 2021?

We were not able to load any forecast data for Acell Inc.

How can I tell whether the Acell Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Acell Inc. Over the past six months, the relative strength of its shares against the market has been %. At the current price of n/a, shares in Acell Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Acell Inc PE Ratio?

We were not able to find PE ratio data for Acell Inc.

Who are the key directors of Acell Inc?

Acell Inc's management team is headed by:

Patrick McBrayer - PRE
Matthew Kunst - CFO
Christopher Branch - VPR
Louis Baldino - CHM
David Anderson - IND
Kyle Kerbawy - IND
Sally Maher - DRC
Martin Pfinsgraff - IND
Who are the major shareholders of Acell Inc?

Here are the top five shareholders of Acell Inc based on the size of their shareholding:

Similar to ACLL
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.